[Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
Glucocorticoid therapy is associated with bone loss starting soon after the therapy is initiated and an increased risk of fracture. Activated forms of vitamin D(3), which are frequently prescribed for postmenopausal osteoporosis in Japan, are one of a useful agent to prevent glucocorticoid-induced osteoporosis. In this review, the effect of activate form vitamin D(3) is compared with plain vitamin D or bisphosphonate.
Imanishi
Yasuo
Y
Osaka City University Graduate School of Medicine, Department of Metabolism, Endocrinology and Molecular Medicine.
Nishizawa
Yoshiki
Y
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002762:Cholecalciferol / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D015201:Meta-Analysis as Topic; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D014807:Vitamin D / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D005938:Glucocorticoids; D014807:Vitamin D; D002762:Cholecalciferol